Expression patterns of α-, β- and γ-catenin in pancreatic cancer: Correlation with E-cadherin expression, pathological features and prognosis

Anticancer Research

Volumn 21, Issue 6 A, 2001, Pages 4127-4134

  Karayiannakis, Anastasios J ^a   Syrigos, Konstantinos N ^a   Polychronidis, Alexandros ^a   Simopoulos, Constantinos ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Catenins; E cadherin; Pancreatic cancer; Prognosis; Survival

Indexed keywords

ALPHA CATENIN; BETA CATENIN; PLAKOGLOBIN; UVOMORULIN;

ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PANCREAS CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ALPHA CATENIN; BETA CATENIN; CADHERINS; CYTOSKELETAL PROTEINS; DESMOPLAKINS; GAMMA CATENIN; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; TRANS-ACTIVATORS;

EID: 0035572340     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Cadherin cell adhesion receptors as a morphogenetic regulator
2. Catenins as mediators of the cytoplasmic functions of cadherins
3. The 102 kd cadherin-associated protein: Similarity to vinculin and posttranscriptional regulation of expression
4. Plakoglobin and β-catenin: Distinct but closely related
5. Defining interactions and distributions of cadherin and catenin complexes in polarized epithelial cells
6. Loss of E-cadherin-dependent cell-cell adhesion due to mutation of the β-catenin gene in a human cancer cell line, HSC-39
7. Cadherin dysfunction in a human cancer cell line: Possible involvement of loss of α-catenin expression in reduced cell-cell adhesiveness
8. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells
9. Expression and potential role of E-cadherin in pancreatic carcinoma
10. Aberrant E-cadherin and α-catenin expression in prostate cancer: Correlation with patient survival
11. E-cadherin/catenin complex in benign and malignant melanocytic lesions
12. E-cadherin expression correlates with tumour differentiation in colorectal cancer
13. Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: Relationship with patient survival
14. Cadherin-catenin expression in primary colorectal cancer: A survival analysis
15. Aberrant E-cadherin expression associated with loss of differentiation and advanced stage in human pancreatic cancer
16. Characterization of the E-cadherin-catenin complexes in pancreatic carcinoma cell lines
17. Histological typing of pancreatic and periampullary carcinoma
18. Staging of exocrine pancreatic carcinoma
19. Loss of membranous E-cadherin expression in pancreatic cancer: Correlation with lymph node metastasis, high grade, and advanced stage
20. Expression patterns of the E-cadherin-catenin cell-cell adhesion complex in gastric cancer
21. Pancreatic carcinoma: Correlation between E-cadherin and α-catenin expression status and liver metastasis
22. Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease
23. β-catenin mediates the interaction of the cadherin-catenin complex with epidermal growth factor receptor
24. Association of the APC gene product with β-catenin
25. c-erbB-2 gene product associates with catenins in human cancer cells
26. Regulation of complexed and free catenin pools by distinct mechanisms. Differential effects of Wnt-1 and v-Src
27. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
28. Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumour aggressiveness
29. Pancreatic cancer: The potential clinical relevance of alterations in growth factors and their receptors
30. Frequent somatic mutations of the APC gene in human pancreatic cancer
31. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis
32. Reduced expression of the cadherin-catenin complex in oesophageal adenocarcinoma correlates with prognosis
33. Relative expression of E-cadherin and type IV collagenase genes predicts disease outcome in patients with resectable pancreatic carcinoma